Introducing PrEP Into HIV Combination Prevention - Kenya

NAUnknownINTERVENTIONAL
Enrollment

2,100

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

April 30, 2017

Conditions
HIV
Interventions
DRUG

Truvada

Daily oral PrEP will be provided to a cohort of 2100 participants (female sex workers, men who have sex with men and young women at high HIV risk) in Kenya. Baseline data will be collected from all participants at enrolment. PrEP users will be followed up at multiple intervals, in months 1, 4, 7, 10 and 12) for 12 months. The PrEP users will attend 7 visits at the project sites over the project period and in between these visits, they will return to the pharmacy for PrEP refill, adherence counselling and assessment of side effects.

Trial Locations (1)

00202

RECRUITING

LVCT Health, Nairobi

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Sex Workers Outreach Project

UNKNOWN

collaborator

National AIDS Control Council

UNKNOWN

collaborator

National AIDS and STI Control Programme

UNKNOWN

collaborator

Health Options for Young Men with AIDS/STI

UNKNOWN

collaborator

Bar Hostess Empowerment & Support Programme

UNKNOWN

collaborator

Gay and Lesbian Coalition Kenya

OTHER

collaborator

ISHTAR MSM

UNKNOWN

collaborator

Kenya Sex Workers Alliance

UNKNOWN

collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

Imperial College London

OTHER

collaborator

Results for Development

UNKNOWN

collaborator

O' Neill Institute

UNKNOWN

collaborator

AVAC

UNKNOWN

collaborator

Nyanza Western Kenya LGBTI Coalition

UNKNOWN

collaborator

World Health Organization

OTHER

collaborator

International AIDS Vaccine Initiative

NETWORK

collaborator

Centres for Disease Control and Prevention, Kenya.

OTHER

lead

LVCT Health

OTHER